Related Experiment Video
Updated: May 15, 2025
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
[A Therapeutic Strategy Targeting Virus-Antigen in Cancer Treatment]
1Dept. of Head and Neck Medical Oncology, National Cancer Center Hospital East.
Abstract:
Evidence has increasingly highlighted the potential of viral antigens as ideal treatment targets for virus-related cancers, primarily due to their exclusive expression on cancer cells and capacity to stimulate robust immune responses and eliminate malignant cells effectively. Innovative approaches such as vaccines tailored to stimulate an immune response, engineered T-cell therapies designed to evidently recognize and destroy cancer cells, and drug delivery methods for selectively expanding and activating virus-antigen-specific T-cells have shown great promise. Numerous studies have indicated that these virus-targeted therapies have potentially improved patient prognostic outcomes with acceptable toxicities. Future research is essential to optimize these approaches and lead them to clinical practice to achieve complete eradication of virus-related cancers.
Insights
Viral antigens show promise as cancer treatment targets. Therapies like vaccines and T-cell treatments effectively target virus-related cancers, improving patient outcomes.
Area of Science:
- Oncology
- Immunology
- Virology
Context:
- Virus-related cancers present unique therapeutic challenges.
- Viral antigens are exclusively expressed on cancer cells, making them ideal targets.
- Existing treatments often have limitations in targeting these specific cancers.
Purpose:
- To explore the potential of viral antigens as therapeutic targets for virus-related cancers.
- To review innovative immunotherapeutic strategies targeting viral antigens.
- To assess the efficacy and safety of these novel approaches.
Summary:
- Viral antigens are highly specific targets for cancer immunotherapy.
- Therapeutic strategies include antigen-specific vaccines and engineered T-cell therapies.
- These approaches aim to stimulate robust immune responses against cancer cells.
- Drug delivery systems are being developed for targeted T-cell activation.
Impact:
- Virus-targeted therapies demonstrate potential for improved patient prognostic outcomes.
- These treatments offer acceptable toxicity profiles.
- Further research is crucial for clinical translation and eradication of virus-related cancers.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Related Concept Videos
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...